Track the 지에프씨생명과학 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지에프씨생명과학 has published 51 public disclosures. Market capitalisation: €27.9bn. The latest transaction was disclosed on 11 August 2026 (Purchase). Among the most active insiders: 강희철. All data is openly available.
36
Insider Decl.
n/a
Thresholds
€2m
22 ops.
Buy Volume
n/a
4 ops.
Sell Volume
3Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,169 of 29,062 companies
36.3
score / 100
Value
28
Quality
45
FCF yld-23%
Earn yld2.0%
EV/EBITDA16.8x
ROE4.1%
Gross mgn48%
Net mgn3.1%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.